EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF THE LOBEGLITAZONE

被引：0
|
作者：
Choi, H.
Jung, J.
Choi, Y.
Seo, J.
Ghim, J.
Kim, E.
Shin, J.
机构：
[1] Inje Univ, Coll Med, Dept Pharmacol, Busan, South Korea
[2] Inje Univ, Coll Med, Pharmacogen Res Ctr, Busan, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2016年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-103
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [21] Effect of Renal or Hepatic Impairment on the Pharmacokinetics of Mirabegron
    Dickinson, James
    Lewand, Michaelene
    Sawamoto, Taiji
    Krauwinkel, Walter
    Schaddelee, Marloes
    Keirns, James
    Kerbusch, Virginie
    Moy, Selina
    Meijer, John
    Kowalski, Donna
    Morton, Richard
    Lasseter, Kenneth
    Riff, Dennis
    Kupcova, Viera
    van Gelderen, Marcel
    [J]. CLINICAL DRUG INVESTIGATION, 2013, 33 (01) : 11 - 23
  • [22] Effect of severe renal impairment on the pharmacokinetics of brigatinib
    Gupta, Neeraj
    Hanley, Michael J.
    Kerstein, David
    Tugnait, Meera
    Narasimhan, Narayana
    Marbury, Thomas C.
    Venkatakrishnan, Karthik
    [J]. INVESTIGATIONAL NEW DRUGS, 2021, 39 (05) : 1306 - 1314
  • [23] CHARACTERISATION OF THE EFFECT OF RENAL IMPAIRMENT ON UPADACITINIB PHARMACOKINETICS
    Mohamed, M. -E. F.
    Coppola, S.
    Feng, T.
    Anderson, J.
    Othman, A. A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1400 - 1401
  • [24] Effect of Hepatic or Renal Impairment on Eltrombopag Pharmacokinetics
    Bauman, John W.
    Vincent, Carolyn T.
    Peng, Bin
    Wire, Mary B.
    Williams, Daphne D.
    Park, Jung Wook
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (05): : 739 - 750
  • [25] Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate
    Maia, J.
    Almeida, L.
    Falcao, A.
    Soares, E.
    Mota, F.
    Potgieter, M. A.
    Potgieter, J. H.
    Soares-da-Silva, P.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2008, 46 (03) : 119 - 130
  • [26] Effect of hepatic or renal impairment on the pharmacokinetics of evacetrapib
    David S. Small
    Wei Zhang
    Jane Royalty
    Ellen A. Cannady
    Delyn Downs
    Demetrio Ortega
    Jeffrey G. Suico
    [J]. European Journal of Clinical Pharmacology, 2016, 72 : 563 - 572
  • [27] Effect of severe renal impairment on the pharmacokinetics of brigatinib
    Neeraj Gupta
    Michael J. Hanley
    David Kerstein
    Meera Tugnait
    Narayana Narasimhan
    Thomas C. Marbury
    Karthik Venkatakrishnan
    [J]. Investigational New Drugs, 2021, 39 : 1306 - 1314
  • [28] Effect of renal impairment on the pharmacokinetics and pharmacodynamics of desirudin
    Lefevre, G
    Duval, M
    Gauron, S
    Brookman, LJ
    Rolan, PE
    Morris, TM
    Piraino, AJ
    Morgan, JM
    Palmisano, M
    Close, P
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (01) : 50 - 59
  • [29] Effect of renal impairment on the pharmacokinetics of antimony in hamsters
    Zaghloul, IY
    Al-Jasser, M
    [J]. ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2004, 98 (08): : 793 - 800
  • [30] Effect of hepatic or renal impairment on the pharmacokinetics of casopitant
    Bauman, John W.
    Antal, Joyce M.
    Adams, Laurel M.
    Johnson, Brendan M.
    Murray, Sharon C.
    Kirby, Lyndon C.
    Lebowitz, Peter F.
    Peng, Bin
    Marbury, Thomas C.
    Swan, Suzanne
    Gutierrez, Maria
    [J]. MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
12345